Top

Current Cardiology Reports

Published in:

24-05-2022 | Atrial Fibrillation | New Therapies for Cardiovascular Disease (AA Bavry and M Massoomi, Section Editors)

Pulsed Field Ablation: a Novel Therapeutic Tool for Catheter-Based Treatment of Atrial Fibrillation

Author: Andrew E. Darby

Published in: Current Cardiology Reports | Issue 7/2022

Abstract

Purpose of Review

With catheter ablation of atrial fibrillation becoming increasingly common, the field of electrophysiology is searching for tools to improve procedural efficacy and safety. This review focuses on a novel ablation tool, pulsed field ablation, which promises to push the needle forward. Pulsed field ablation uses high-frequency electrical pulses to ablate cardiac tissue.

Recent Findings

A number of pre-clinical and clinical studies have shown pulsed field ablation offers an efficient means of ablating cardiac tissue with minimal risk of collateral injury.

Summary

Pulsed field ablation provides a non-thermal means of cardiac tissue ablation with minimal risk of injury to adjacent structures. Future studies will define the optimal current delivery, number of lesions needed to achieve the desired tissue effect, and how best to integrate pulsed field ablation catheters into 3-dimensional mapping systems.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444. https://doi.org/10.1016/j.hrthm.2017.05.012.CrossRefPubMedPubMedCentral

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. JAMA. 2019;321(13):1261–74. https://doi.org/10.1001/jama.2019.0693.CrossRefPubMedPubMedCentral

Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–27. https://doi.org/10.1056/NEJMoa1707855.CrossRefPubMed

Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384:305–15. https://doi.org/10.1056/NEJMoa2029980.CrossRefPubMed

Callans DJ, Gerstenfeld EP, Dixit S, Zado E, Vanderhoff M, Ren JF, et al. Efficacy of repeat pulmonary vein isolation procedures in patient with recurrent atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15:1050–5. https://doi.org/10.1046/j1540-8167.2004.04052.x.CrossRefPubMed

Nery PB, Belliveau D, Nair GM, Bernick J, Redpath C, Szczotka A, et al. Relationship between pulmonary vein reconnection and atrial arrhythmia recurrence. J Am Coll Cardiol EP. 2016;2:474–83. https://doi.org/10.1016/j.jacep.2016.02.003.CrossRef

Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):349–361. https://doi.org/10.1161/CIRCEP.108.824789

Turagam MK, Musikantow D, Whang W, Koruth JS, Miller MA, Langan MN, et al. JAMA Cardiol. 2021;6(6):697–705. https://doi.org/10.1001/jamacardio.2021.0852.CrossRefPubMed

• Verma A, Asirvatham S, Deneke, T, Castellvi Q, Neal RE. Primer on pulsed field ablation: understanding the benefits and limitations. Circulation: Arrhythmia and Electrophysiology 2021;14:902–917. https://doi.org/10.1161/CIRCEP.121.010086. This review provides an excellent overview of pulsed field ablation including the biophysics and various ablation catheter designs.

10.

Rubinsky L, Guenther E, Mikus P, Stehling M, Rubinsky B. Electrolytic effects during tissue ablation by electroporation. Technol Cancer Res Treat. 2016;15:NP95–NP103. https://doi.org/10.1177/1533034615601549

11.

Xie F, Varghese F, Pakhomov AG, Semenov I, Xiao S, Philpott J, et al. Ablation of myocardial tissue with nanosecond pulsed electric fields. PLoS ONE. 2015;10: e0144833. https://doi.org/10.1371/journal.pone.0144833.CrossRefPubMedPubMedCentral

12.

Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31. https://doi.org/10.1007/s10439-005-8981-8.CrossRefPubMed

13.

Bradley CJ, Haines DE. Pulsed field ablation for pulmonary vein isolation in the treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31:2136–47. https://doi.org/10.1111/jce.14414.CrossRefPubMed

14.

Deodhar A, Dickfeld T, Single GW, Hamilton WC, Thornton RH, Sofocleous CT, et al. AJR Am J Roentgenol. 2011;196(3):W330–5. https://doi.org/10.2214/AJR.10.4490.CrossRefPubMedPubMedCentral

15.

Wittkampf FH, Van Driel VJ, Van Wessel H, Wink A, Hof IE, Grundeman PF, et al. Feasibility of electroporation for the creation of pulmonary vein ostial lesions. J Cardiovasc Electrophysiol. 2011;22(3):302–9. https://doi.org/10.1111/j.1540-8167.2010.01863.x.CrossRefPubMed

16.

Reddy VY, Anter E, Rackauskas G, Peichl P, Koruth JS, Petru J, et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial. Circulation: Arrhythmia and Electrophysiology. 2020;13:e008718. https://doi.org/10.1161/CIRCEP.120.008718

17.

Anic A. Safety and feasibility of pulsed field ablation with the centauri system for patients with atrial fibrillation. EP Europace. 2021;23:ii9–ii13.

18.

Wittkampf FHM, van Es R, Neven K. Electroporation and its relevance for cardiac catheter ablation. JACC Clin Electrophysiol. 2018;4:977–86. https://doi.org/10.1016/j.jacep.2018.06.005.CrossRefPubMed

19.

Reddy VY, Koruth J, Jais P, Petru J, Timko F, Skalsky I, et al. Ablation of atrial fibrillation with pulsed electric fields: an ultra-rapid, tissue selective modality for cardiac ablation. JACC Clin Electrophysiol. 2018;4:987–95. https://doi.org/10.1016/j.jacep.2018.04.005.CrossRefPubMed

20.

Verma A, Boersma L, Hummel J, Calkins H, Sanders P, Haines DE, et al. PULSED AF: First human experience and acute procedural outcomes using a novel pulsed field ablation system. Circulation: Arrhythmia and Electrophysiology. 2022;15(1). https://doi.org/10.1161/CIRCEP.121.010168

21.

Koruth J, Kuroki K, Kawamura I, Brose R, Viswanathan R, Buck E, et al. Pulsed field ablation vs radiofrequency ablation: esophageal injury in a novel porcine model. Circulation: Arrhythmia and Electrophysiology 2020;13:e008303. https://doi.org/10.1161/CIRCEP.119.008303.

22.

Stewart MT, Haines DE, Verma A, Kirchhof N, Barka N, Grassl E, et al. Intracardiac pulsed field ablation: proof of feasibility in a chronic porcine model. Heart Rhythm. 2019;16:754–64. https://doi.org/10.1016/j.hrthm.2018.10.030.CrossRefPubMed

23.

Neven K, van Driel V, van Wessel H, van Es R, Doevendans PA, Wittkampf F. Myocardial lesion size after epicardial electroporation catheter ablation after subxiphoid puncture. Circulation: Arrhythmia and Electrophysiology. 2014;7(4):728–733. https://doi.org/10.1161/CIRCEP.114.001659

24.

Wittkampf FHM, van Driel VJ, avn Wessel H, Neven KGEJ, Grundeman PF, Vink A, et al. Myocardial lesion depth with circular electroporation ablation. Circulation: Arrhythmia and Electrophysiology. 2012;5:581–586. https://doi.org/10.1161/CIRCEP.111.970079

25.

Nakatani Y, Sridi-Cheniti S, Cheniti G, Ramirez FD, Goujeau C, Andre C, et al. Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation. EP Europace. 2021;23(11):1767–76. https://doi.org/10.1093/europace/euab155.CrossRef

26.

Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation. 2004;109(22):2724–6. https://doi.org/10.1161/01.CIR.0000131866.44650.46.CrossRefPubMed

27.

Ahmed H, Neuzil P, d’Avila A, Cha YM, Laragy M, Mares K, et al. The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm. 2009;6(7):962–9. https://doi.org/10.1016/j.hrthm.2009.03.051.CrossRefPubMed

28.

Hong J, Stewart MT, Cheek DS, Francischelli DE, Kirchof N. Cardiac ablation via electroporation. Conf Proc IEEE Eng Med Biol Soc 2009;3381–3384. https://doi.org/10.1109/IEMBS.2009.5332816

29.

Sacher F, Monahan KH, Thomas SP, Davidson N, Adragao P, Sanders P, et al. Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol. 2006;47(12):2498–503. https://doi.org/10.1016/j.jacc.2006.02.050.CrossRefPubMed

30.

Kuck KH, Furnkranz A. Cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(12):1427–31. https://doi.org/10.1111/j.1540-8167.2010.01944.x.CrossRefPubMed

31.

Tokuda M, Yamashita S, Sato H, Oseto H, Ikewaki H, Yokoyama M, et al. Long-term course of phrenic nerve injury after cryoballoon ablation of atrial fibrillation. Scientific Reports. 2021;11. https://doi.org/10.1038/s41598-021-85618-3

32.

Andrade JG, Dubuc M, Ferreira J, Guerra PG, Landry E, Coulombe N, et al. Histopathology of cryoballoon ablation-induced phrenic nerve injury. J Cardiovasc Electrophysiol. 2013;25(2):187–94. https://doi.org/10.1111/jce.12296.CrossRefPubMed

33.

van Driel VJHM, Neven K, van Wessel H, Vink A, Doevendans PAFM, Wittkampf FDM. Low vulnerability of the right phrenic nerve to electroporation ablation. Heart Rhythm. 2015;12(8):1838–44. https://doi.org/10.1016/j.hrthm.2015.05.012.CrossRefPubMed

34.

Holmes DR, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv. 2009;2(4):267–76. https://doi.org/10.1016/j.mcin.2008.12.014.CrossRefPubMed

35.

van Driel VJ, Neven KG, van Wessel H, du Pre BC, Wink A, Doevendans PAFM, et al. Pulmonary vein stenosis after catheter ablation: electroporation versus radiofrequency. Circulation: Arrhythmia and Electrophysiology 2014;7(4):734–738. https://doi.org/10.1161/CIRCEP.113.001111

36.

Howard B, Haines D, Verma A, Packer D, Kirchhof N, Barka N, et al. Reduction in pulmonary vein stenosis and collateral damage with pulsed field ablation compared with radiofrequency ablation in a canine model. Circulation: Arrhythmia and Electrophysiology. 2020;13:e008337. https://doi.org/10.1161/CIRCEP.120.008337

37.

Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74(3):315–26. https://doi.org/10.1016/j.jacc.2019.04.021.CrossRefPubMed

38.

•• Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7:614–27. https://doi.org/10.1016/j.jacep.2021.02.014. This recent publication reported results of 3 trials using pulsed field ablation in the treatment of paroxysmal atrial fibrillation.CrossRefPubMed

39.

Loh P, van Es R, Groen MHA, Neven K, Kassenberg W, Wittkampf FHM, et al. Pulmonary vein isolation with single pulse irreversible electroporation: a first in human study in 10 patients with atrial fibrillation. Circulation: Arrhythmia and Electrophysiology. 2020;13:e008192. https://doi.org/10.1161/CIRCEP.119.008192

40.

Reddy VY, Anic A, Koruth J, Petru J, Funasako M, Minami K, et al. Pulsed field ablation in patients with persistent atrial fibrillation. J Am Coll Cardiol. 2020;76:1068–80. https://doi.org/10.1016/j.jacc.2020.07.007.CrossRefPubMed

41.

Gunawardene MA, Schaeffer BN, Jularic M, Eickholt C, Maurer T, Akbulak RO, et al. Pulsed field ablation combined wtih ultrahigh-density mapping in patients undergoing catheter ablation for atrial fibrillation: practical and electrophysiological considerations. J Cardiovasc Electrophysiol. 2022;1-12. https://doi.org/10.1111/jce.15349

42.

Kapur S, Barbhaiya C, Deneke T, Michaud G. Esophageal injury and atrioesophageal fistula caused by ablation for atrial fibrillation. Circulation. 2017;136:1247–55. https://doi.org/10.1161/CIRCULATIONAHA.117.025827.CrossRefPubMed

Title: Pulsed Field Ablation: a Novel Therapeutic Tool for Catheter-Based Treatment of Atrial Fibrillation
Author: Andrew E. Darby
Publication date: 24-05-2022
Publisher: Springer US
Keyword: Atrial Fibrillation
Published in: Current Cardiology Reports / Issue 7/2022
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-022-01697-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The STEP trials

Springer Medicine

Pulsed Field Ablation: a Novel Therapeutic Tool for Catheter-Based Treatment of Atrial Fibrillation

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 7/2022

Safety and Efficacy of Robotic-Assisted PCI

Atherectomy vs Other Modalities for Treatment During Peripheral Vascular Intervention

Alternative Nuclear Imaging Tools for Infection Imaging

Assessment of Cardiac Risk in Women with Autoimmune Disease

How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?

It Takes a Village: Expanding Women’s Cardiovascular Care to Include the Community as well as Cardiovascular and Primary Care Teams

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page